Home›Search›Diabetologie Metabolismus Endokrinologie Vyziva

Diabetologie Metabolismus Endokrinologie Vyziva

TIGIS Spol. s.r.o. · Czech Republic

ISSN1212-6853

SJR Q4✓ Scopus / SJR

Journal Impact Factor

Not on record at PubScope. The Journal Impact Factor is published by Clarivate for Web of Science (JCR)–indexed journals.

📊 Standing in its field

Where this journal ranks among others in the same subject area.

SJR · Scopus

Bottom 25%

Clarivate’s JCR quartile is a separate ranking and may differ

SJR Scorei

0.112

H-Indexi

SNIPi

0.039

Aims & Scope✦ Compiled from public sources

Diabetologie Metabolismus Endokrinologie Vyziva is a journal that publishes articles on the inhibition of 11β-hydroxysteroid dehydrogenase type 1 as a potential treatment of diabetes, obesity, and metabolic syndrome.

AI-compiled from public web sources · verify on the publisher page

General Information

Country / RegionCzech Republic

Primary Language—

1st Year Published—

Frequency3x/year

StatusActive

Total Publications—

Submission Info

Peer Review—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

4/11 · 36%

✅

Do you know the journal / publisher?

TIGIS Spol. s.r.o.

❌

Does the journal have a website?

No URL

✅

Is the ISSN verified?

1212-6853

✅

Indexed in a trusted database?

Scopus

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

❌

Primary language documented?

N/A

A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

EndocrinologyQ4

Endocrinology, Diabetes and MetabolismQ4

Internal MedicineQ4

Subject Classification

Scopus Categories

Endocrinology, Diabetes and MetabolismEndocrinologyInternal Medicine

Frequently asked questions about Diabetologie Metabolismus Endokrinologie Vyziva

Is Diabetologie Metabolismus Endokrinologie Vyziva a predatory journal?

PubScope has no integrity flags on record for Diabetologie Metabolismus Endokrinologie Vyziva: it is indexed in Scopus, and is not on DOAJ's withdrawn list. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Diabetologie Metabolismus Endokrinologie Vyziva?

Diabetologie Metabolismus Endokrinologie Vyziva is not in the Web of Science Core Collection, so it has no official Clarivate Journal Impact Factor. Its SCImago SJR score is 0.112.

Is Diabetologie Metabolismus Endokrinologie Vyziva indexed in Scopus and Web of Science?

Diabetologie Metabolismus Endokrinologie Vyziva is indexed in Scopus.